Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial

Eik Dybboe Bjerre, Klaus Brasso, Anders Bojer Jørgensen, Thomas Hindborg Petersen, Alexandra Röthlin Eriksen, Anders Tolver, Jesper Frank Christensen, Mads Hvid Poulsen, Søren Sørensen Madsen, Peter Busch Østergren, Michael Borre, Peter Krustrup, Christoffer Johansen, Mikael Rørth, Julie Midtgaard, Eik Dybboe Bjerre, Klaus Brasso, Anders Bojer Jørgensen, Thomas Hindborg Petersen, Alexandra Röthlin Eriksen, Anders Tolver, Jesper Frank Christensen, Mads Hvid Poulsen, Søren Sørensen Madsen, Peter Busch Østergren, Michael Borre, Peter Krustrup, Christoffer Johansen, Mikael Rørth, Julie Midtgaard

Abstract

Background: Physical activity has been shown to mitigate the unwanted psychological and physiological side effects of prostate cancer treatments, but sustainable exercise possibilities are limited.

Objective: Our objective was to examine whether football in a real-world setting (i.e., local football clubs) was safe and feasible in practice and could improve quality of life, mitigate decline in muscle mass and bone density, and increase fat mass in patients with prostate cancer.

Methods: In this pragmatic, multicentre, parallel randomized controlled trial, men diagnosed with prostate cancer were recruited from five Danish urological departments. Men (N = 214) diagnosed with prostate cancer were randomly allocated, using random generated lists (block size 4-8) stratified for center and androgen-deprivation therapy status, to either 1 h of football twice weekly in a local football club or to usual care, which was a 15- to 30-min telephone session covering their options for physical activity or free-of-charge rehabilitation delivered as standard in Denmark. Allocation was concealed from the trial investigator performing the randomization, but-given the nature of the intervention-this was not possible for personnel and participants. Assessments were performed at baseline, 12 weeks, and 6 months. The primary outcome was mean change difference in prostate cancer-specific quality of life at 12 weeks. Secondary outcomes were body composition, 12-Item Short Form Health Survey (SF-12) physical and mental health, and safety-reported as fractures, falls, and serious adverse events.

Results: Attrition was 1 and 3% at 12 weeks, and 5% and 5% at 6 months for the usual care and football groups, respectively. Prostate cancer-specific quality of life was equal between groups at 12 weeks (mean difference + 1.9 points, 95% confidence interval [CI] -1.0-4.8; P = 0.20) and at 6 months (+ 0.5 points, 95% CI -2.8-3.8; P = 0.76). Fractures were equally distributed, with two fractures in the usual care group and one in the football group. Likewise, body composition outcomes were equal. Mental health improved after 6 months of football (mean difference + 2.7 points, 95% CI 0.8-4.6; P = 0.006).

Conclusions: In this trial, community-based football was a feasible exercise strategy for men with prostate cancer. Football did not improve prostate cancer-specific quality of life but did improve mental health; the clinical significance of this is unclear.

Trial registration: ClinicalTrials.gov: NCT02430792.

Conflict of interest statement

Ethical Approval

The study was approved by the Ethics Committee for the Capital Region of Denmark (H-2-2014-099) and the Danish Data Protection Agency. All participants provided informed consent before participating.

Conflicts of Interest

All authors have completed the Unified Competing Interest form (available on request from the corresponding author) and received no support from any organization for the submitted work. Eik Dybboe Bjerre, Klaus Brasso, Anders Bojer Jørgensen, Thomas Hindborg Petersen, Alexandra Röthlin Eriksen, Anders Tolver, Jesper Frank Christensen, Mads Hvid Poulsen, Søren Sørensen Madsen, Peter Busch Østergren, Michael Borre, Christoffer Johansen, Mikael Rørth, and Julie Midtgaard have had no financial relationships with any organizations that might have an interest in the submitted work in the previous 3 years. Peter Krustrup has received funding for other research activities from the DBU, Union of European Football Associations (UEFA) and FIFA in the previous 3 years. No other relationships or activities could have influenced the submitted work.

Availability of Data and Materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Figures

Fig. 1
Fig. 1
Flow of participants. DXA Dual-energy X-ray absorptiometry, Pca prostate cancer, () DXA lost to follow up
Fig. 2
Fig. 2
Mean change in outcomes, according to allocation group and time points. QoL quality of life, BMD bone mineral density
Fig. 3
Fig. 3
Weekly MET minutes, according to allocation group. MET metabolic Equivalent
Fig. 4
Fig. 4
Mean changes in body composition based on baseline physical activity

References

    1. Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, Abdulkader RS, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259. doi: 10.1016/S0140-6736(17)32154-2.
    1. Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, Abera SF, Aboyans V, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi: 10.1016/S0140-6736(17)32152-9.
    1. Skolarus TA, Wolf AMD, Erb NL, Brooks DD, Rivers BM, Underwood W, et al. American Cancer Society prostate cancer survivorship care guidelines. CA Cancer J Clin. 2014;64(4):225–249. doi: 10.3322/caac.21234.
    1. Gilbert SM, Kuo YF, Shahinian VB. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States. Urol Oncol. 2011;29(6):647–653. doi: 10.1016/j.urolonc.2009.09.004.
    1. Donovan KA, Walker LM, Wassersug RJ, Thompson LM, Robinson JW. Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners. Cancer. 2015;121(24):4286–4299. doi: 10.1002/cncr.29672.
    1. Alibhai SM, Breunis H, Timilshina N, Naglie G, Tannock I, Krahn M, et al. Long-term impact of androgen-deprivation therapy on physical function and quality of life. Cancer. 2015;121(14):2350–2357. doi: 10.1002/cncr.29355.
    1. Nguyen PL, Alibhai SM, Basaria S, D’Amico AV, Kantoff PW, Keating NL, et al. Adverse effects of androgen deprivation therapy and strategies to mitigate them. Eur Urol. 2015;67(5):825–836. doi: 10.1016/j.eururo.2014.07.010.
    1. Gardner JR, Livingston PM, Fraser SF. Effects of exercise on treatment-related adverse effects for patients with prostate cancer receiving androgen-deprivation therapy: a systematic review. J Clin Oncol. 2014;32(4):335–346. doi: 10.1200/JCO.2013.49.5523.
    1. Bourke L, Smith D, Steed L, Hooper R, Carter A, Catto J, et al. Exercise for men with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;69(4):693–703. doi: 10.1016/j.eururo.2015.10.047.
    1. Kenfield SA, Stampfer MJ, Giovannucci E, Chan JM. Physical activity and survival after prostate cancer diagnosis in the health professionals follow-up study. J Clin Oncol. 2011;29(6):726–732. doi: 10.1200/JCO.2010.31.5226.
    1. Parsons JK. Prostate cancer and the therapeutic benefits of structured exercise. J Clin Oncol. 2014;32(4):271–272. doi: 10.1200/JCO.2013.53.4289.
    1. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350:h2147. doi: 10.1136/bmj.h2147.
    1. Uth J, Hornstrup T, Schmidt JF, Christensen JF, Frandsen C, Christensen KB, et al. Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy. Scand J Med Sci Sports. 2014;24(Suppl 1):105–112. doi: 10.1111/sms.12260.
    1. Uth J, Hornstrup T, Christensen JF, Christensen KB, Jorgensen NR, Schmidt JF, et al. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial. Osteopor Int. 2016;27(4):1507–1518. doi: 10.1007/s00198-015-3399-0.
    1. Bruun DM, Bjerre E, Krustrup P, Brasso K, Johansen C, Rorth M, et al. Community-based recreational football: a novel approach to promote physical activity and quality of life in prostate cancer survivors. Int J Environ Res Pub Health. 2014;11(6):5567–5585. doi: 10.3390/ijerph110605567.
    1. Khan KM, Thompson AM, Blair SN, Sallis JF, Powell KE, Bull FC, et al. Sport and exercise as contributors to the health of nations. Lancet (London, England). 2012;380(9836):59–64. doi: 10.1016/S0140-6736(12)60865-4.
    1. Reis RS, Salvo D, Ogilvie D, Lambert EV, Goenka S, Brownson RC. Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving. Lancet (London, England). 2016;388(10051):1337–1348. doi: 10.1016/S0140-6736(16)30728-0.
    1. Bjerre E, Bruun DM, Tolver A, Brasso K, Krustrup P, Johansen C, et al. Effectiveness of community-based football compared to usual care in men with prostate cancer: protocol for a randomised, controlled, parallel group, multicenter superiority trial (The FC Prostate Community Trial) BMC Cancer. 2016;16(1):767. doi: 10.1186/s12885-016-2805-0.
    1. Bjerre ED, Leth M, Hammer NM, Midtgaard J. Development of an educational program for non-professional soccer coaches in charge of community-based soccer in men with prostate cancer: a qualitative study. Sports Med Open. 2018;4(1):31. doi: 10.1186/s40798-018-0147-y.
    1. Sundhedsstyrelsen. Fysisk aktivitet—håndbog om forebyggelse og behandling. 3.1 edn. Rosendahls-Schultz Grafisk A/S; 2011.
    1. Soligard T, Myklebust G, Steffen K, Holme I, Silvers H, Bizzini M, et al. Comprehensive warm-up programme to prevent injuries in young female footballers: cluster randomised controlled trial. BMJ. 2008;337:a2469. doi: 10.1136/bmj.a2469.
    1. Kristiansen M, Adamsen L, Piil K, Halvorsen I, Nyholm N, Hendriksen C. A three-year national follow-up study on the development of community-level cancer rehabilitation in Denmark. Scand J Pub Health. 2017. 10.1177/1403494817746535.
    1. Esper P, Mo F, Chodak G, Sinner M, Cella D, Pienta KJ. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument. Urology. 1997;50(6):920–928. doi: 10.1016/S0090-4295(97)00459-7.
    1. Sprangers MA. Response-shift bias: a challenge to the assessment of patients’ quality of life in cancer clinical trials. Cancer Trea Rev. 1996;22(Suppl A):55–62. doi: 10.1016/S0305-7372(96)90064-X.
    1. Group IEW. ICH Harmonised Tripartite Guideline. Clinical safety data management: definitions and standards for expedited reporting. Step 4 version. 1994.
    1. Cella D, Nichol MB, Eton D, Nelson JB, Mulani P. Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy–Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer. Value Health. 2009;12(1):124–129. doi: 10.1111/j.1524-4733.2008.00409.x.
    1. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21(9):1653–1659. doi: 10.1200/JCO.2003.09.534.
    1. IPAQ. Guidelines for data processing and analysis of the international physical activity questionnaire (IPAQ)—short and long forms, revised on November 2005. Accessed 10 Nov 2015.
    1. Hernán MA, Hernandez-Diaz S, Robins JM. Randomized trials analyzed as observational studies. Ann Intern Med. 2013;159(8):560–562.
    1. Smith MR, Finkelstein JS, McGovern FJ, Zietman AL, Fallon MA, Schoenfeld DA, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002;87(2):599–603. doi: 10.1210/jcem.87.2.8299.
    1. Herr HW, O’Sullivan M. Quality of life of asymptomatic men with nonmetastatic prostate cancer on androgen deprivation therapy. J Urol. 2000;163(6):1743–1746. doi: 10.1016/S0022-5347(05)67533-7.
    1. Taaffe DR, Newton RU, Spry N, Joseph D, Chambers SK, Gardiner RA, et al. Effects of different exercise modalities on fatigue in prostate cancer patients undergoing androgen deprivation therapy: a year-long randomised controlled trial. Eur Urol. 2017;72(2):293–299. doi: 10.1016/j.eururo.2017.02.019.
    1. Uth J, Hornstrup T, Christensen JF, Christensen KB, Jorgensen NR, Helge EW, et al. Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations. Eur J Appl Physiol. 2016;116(3):471–480. doi: 10.1007/s00421-015-3301-y.
    1. Yunfeng G, Weiyang H, Xueyang H, Yilong H, Xin G. Exercise overcome adverse effects among prostate cancer patients receiving androgen deprivation therapy: an update meta-analysis. Medicine. 2017;96(27):e7368. doi: 10.1097/MD.0000000000007368.
    1. Vashistha V, Singh B, Kaur S, Prokop LJ, Kaushik D. The effects of exercise on fatigue, quality of life, and psychological function for men with prostate cancer: systematic review and meta-analyses. Eur Urol Focus. 2016;2(3):284–295. doi: 10.1016/j.euf.2016.02.011.
    1. Teleni L, Chan RJ, Chan A, Isenring EA, Vela I, Inder WJ, et al. Exercise improves quality of life in androgen deprivation therapy-treated prostate cancer: systematic review of randomised controlled trials. Endocr Relat Cancer. 2016;23(2):101–112. doi: 10.1530/ERC-15-0456.
    1. Cormie P, Newton RU, Spry N, Joseph D, Taaffe DR, Galvao DA. Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases. Prostate Cancer Prostatic Dis. 2013;16(4):328–335. doi: 10.1038/pcan.2013.22.
    1. Galvão DA, Taaffe DR, Spry N, Cormie P, Joseph D, Chambers SK, et al. Exercise preserves physical function in prostate cancer patients with bone metastases. Med Sci Sports Exerc. 2018;50(3):393–399. doi: 10.1249/MSS.0000000000001454.
    1. Bruun DM, Krustrup P, Hornstrup T, Uth J, Brasso K, Rorth M, et al. “All boys and men can play football”: a qualitative investigation of recreational football in prostate cancer patients. Scand J Med Sci Sports. 2014;24(Suppl 1):113–121. doi: 10.1111/sms.12193.
    1. Heidi Hesselberg HL, Maj Bjerre, Lea Graff, Tine Rostgaard, Freya Casier, Torben Fridberg. Rehabilitering PÅ Ældreområdet. Afprøvning Af En model for rehabiliterinsforløb I to kommuner. København: SFI—Det Nationale Forskningscenter for Velfærd; 2017.

Source: PubMed

Подписаться